The use of AVs expressing tumor necrosis factor (TNF)-α or IFN-γ introduced into tumors enhanced infiltration of CD4 and CD8 positive T cells in addition to increasing expression of MHC class I and II on the tumor cells in a mouse glioma model. Here, TNF is linked to glioma.